Artículos de revistas sobre el tema "Triple negative breast cancers"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Triple negative breast cancers".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ray, Mandira y Blase N. Polite. "Triple-Negative Breast Cancers". Cancer Journal 16, n.º 1 (enero de 2010): 17–22. http://dx.doi.org/10.1097/ppo.0b013e3181d3eef5.
Texto completoGonzalez, Lorena, Joanne Mortimer y Laura Kruper. "De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer". Current Breast Cancer Reports 13, n.º 3 (14 de junio de 2021): 151–56. http://dx.doi.org/10.1007/s12609-021-00421-3.
Texto completoAnderson, Kristin, Patricia Thompson, Betsy Wertheim, Lorena Martin, Ian K. Komenaka, Melissa Bondy, Adrian Daneri-Navarro et al. "Family history and breast cancer subtype among women of Mexican descent." Journal of Clinical Oncology 32, n.º 26_suppl (10 de septiembre de 2014): 41. http://dx.doi.org/10.1200/jco.2014.32.26_suppl.41.
Texto completoSTADALNYKAITĖ, Sigutė y Rūta BRIEDIENĖ. "Radiological diagnostics of triple negative breast cancer: a review". Acta medica Lituanica 18, n.º 2 (1 de abril de 2011): 98–106. http://dx.doi.org/10.6001/actamedica.v18i2.1822.
Texto completoLu, Boya, Elango Natarajan, Hanumantha Rao Balaji Raghavendran y Uma Devi Markandan. "Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review". Technology in Cancer Research & Treatment 22 (enero de 2023): 153303382211452. http://dx.doi.org/10.1177/15330338221145246.
Texto completoBhatti, Abu Bakar Hafeez, Amina Iqbal Khan, Neelam Siddiqui, Narjis Muzaffar y Mazhar Ali Shah. "Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conservative therapy." Journal of Clinical Oncology 31, n.º 26_suppl (10 de septiembre de 2013): 70. http://dx.doi.org/10.1200/jco.2013.31.26_suppl.70.
Texto completoKuo, Wen-Hung, Yao-Yin Chang, Ming-Feng Hou, Eric Y. Chuang y King-Jen Chang. "Molecular characteristics and metastasis predictor genes of triple-negative breast cancer." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): 1043. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1043.
Texto completoChirappapha, Prakasit, Thongchai Sukarayothin, Yodying Wasuthit, Ronnarat Suvikapalornkul, Panuwat Lertsithichai y Youwanush Kongdan. "Disease-free Probability and Triple-Negative Breast Cancer". Ramathibodi Medical Journal 35, n.º 1 (30 de marzo de 2012): 5–13. http://dx.doi.org/10.33165/rmj.2012.35.1.117663.
Texto completoZoghi, Behyar y Peter Ravdin. "Improving the efficacy of chemotherapy drugs for the treatment of triple-negative breast cancers." Journal of Clinical Oncology 30, n.º 27_suppl (20 de septiembre de 2012): 107. http://dx.doi.org/10.1200/jco.2012.30.27_suppl.107.
Texto completoAndre, F., P. Dessen, B. Job, S. Delaloge, L. Pusztai y V. Lazar. "Functional pathways analyses to identify candidate therapeutic targets in triple-negative breast cancer". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 569. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.569.
Texto completoSener Dede, D., S. Aksoy, N. Bulut, O. Dizdar, Z. Arik, I. Gullu, Y. Ozisik y K. Altundag. "Comparison of serum levels of CEA and CA 15–3 in triple-negative breast cancer at the time of metastases and serum levels at the time of first diagnosis". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): e12017-e12017. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e12017.
Texto completoMinami, Christina A., Debra U. Chung y Helena R. Chang. "Management Options in Triple-Negative Breast Cancer". Breast Cancer: Basic and Clinical Research 5 (enero de 2011): BCBCR.S6562. http://dx.doi.org/10.4137/bcbcr.s6562.
Texto completoGierach, Gretchen L., Aileen Burke y William F. Anderson. "Epidemiology of triple negative breast cancers". Breast Disease 32, n.º 1-2 (15 de marzo de 2011): 5–24. http://dx.doi.org/10.3233/bd-2010-0319.
Texto completoHubalek, Michael, Theresa Czech y Hannes Müller. "Biological Subtypes of Triple-Negative Breast Cancer". Breast Care 12, n.º 1 (2017): 8–14. http://dx.doi.org/10.1159/000455820.
Texto completoTsang, J., T. L. Lai, D. H. Lau, G. K. Au y D. T. Chua. "Triple-negative breast cancer in Hong Kong Chinese patients". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): e22127-e22127. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e22127.
Texto completoGadi, Vijayakrishna K. y Nancy E. Davidson. "Practical Approach to Triple-Negative Breast Cancer". Journal of Oncology Practice 13, n.º 5 (mayo de 2017): 293–300. http://dx.doi.org/10.1200/jop.2017.022632.
Texto completoNandini, Dey, Aske Jennifer y De Pradip. "Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive". Pharmaceuticals 14, n.º 5 (12 de mayo de 2021): 455. http://dx.doi.org/10.3390/ph14050455.
Texto completoKubouchi, Koichi, Kyosuke Shimada, Takamichi Yokoe y Yutaka Tsutsumi. "Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions". Technology in Cancer Research & Treatment 19 (1 de enero de 2020): 153303382094324. http://dx.doi.org/10.1177/1533033820943246.
Texto completoBredel, Markus, Hyunsoo Kim, Nanda K. Thudi, Denise M. Scholtens, James A. Bonner y Branimir I. Sikic. "NFKBIA deletion in triple-negative breast cancer." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 1012. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1012.
Texto completoAmirifard, Nasrin, Edris Sadeghi y Mansour Choubsaz. "Triple-Negative Breast Cancer Survival in Kurdish Patients". Scholars Journal of Applied Medical Sciences 4, n.º 7 (julio de 2016): 2732–35. http://dx.doi.org/10.21276/sjams.2016.4.7.89.
Texto completoParry, S., K. Savage, C. Marchiò y J. S. Reis-Filho. "Nestin is expressed in basal-like and triple negative breast cancers". Journal of Clinical Pathology 61, n.º 9 (19 de julio de 2008): 1045–50. http://dx.doi.org/10.1136/jcp.2008.058750.
Texto completoWu, Jiande, Tarun Karthik Kumar Mamidi, Lu Zhang y Chindo Hicks. "Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer". Cancers 12, n.º 6 (12 de junio de 2020): 1559. http://dx.doi.org/10.3390/cancers12061559.
Texto completoSharma, D., B. B. Knight, R. Yacoub, T. Liu, L. Taliaferro-Smith, A. Nagalingam y R. M. O'Regan. "Using epigenetic reprogramming to target triple-negative breast cancer". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): e14565-e14565. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e14565.
Texto completoEZZET, Alaa Anwer, Isik Didem KARAGOZ, Sibel CANGI y Tulay KUS. "DNA Profiling of ING1 Gene in Triple Negative Breast Cancer". Eurasia Proceedings of Science Technology Engineering and Mathematics 22 (30 de agosto de 2023): 280–84. http://dx.doi.org/10.55549/epstem.1350983.
Texto completoVoutsadakis, Ioannis A. "EMT Features in Claudin-Low versus Claudin-Non-Suppressed Breast Cancers and the Role of Epigenetic Modifications". Current Issues in Molecular Biology 45, n.º 7 (19 de julio de 2023): 6040–54. http://dx.doi.org/10.3390/cimb45070381.
Texto completoRiaz, Fauzia. "New strategies for the management of triple-negative breast cancer". Current Opinion in Obstetrics & Gynecology 36, n.º 1 (8 de diciembre de 2023): 40–44. http://dx.doi.org/10.1097/gco.0000000000000927.
Texto completoPerou, Charles M. "Molecular Stratification of Triple‐Negative Breast Cancers". Oncologist 15, S5 (noviembre de 2010): 39–48. http://dx.doi.org/10.1634/theoncologist.2010-s5-39.
Texto completoPerou, Charles M. "Molecular Stratification of Triple‐Negative Breast Cancers". Oncologist 16, S1 (enero de 2011): 61–70. http://dx.doi.org/10.1634/theoncologist.2011-s1-61.
Texto completoJoensuu, H. y J. Gligorov. "Adjuvant treatments for triple-negative breast cancers". Annals of Oncology 23 (agosto de 2012): vi40—vi45. http://dx.doi.org/10.1093/annonc/mds194.
Texto completoVaidyanathan, Kannan. "The Challenge of Triple Negative Breast Cancers". Indian Journal of Clinical Biochemistry 29, n.º 3 (14 de junio de 2014): 267–68. http://dx.doi.org/10.1007/s12291-014-0453-1.
Texto completoByrne, David J., Siddhartha Deb, Elena A. Takano y Stephen B. Fox. "GATA3 expression in triple-negative breast cancers". Histopathology 71, n.º 1 (19 de abril de 2017): 63–71. http://dx.doi.org/10.1111/his.13187.
Texto completoAlluri, Prasanna y Lisa A. Newman. "Basal-Like and Triple-Negative Breast Cancers". Surgical Oncology Clinics of North America 23, n.º 3 (julio de 2014): 567–77. http://dx.doi.org/10.1016/j.soc.2014.03.003.
Texto completoBoukerroucha, M., C. Josse, S. ElGuendi, P. Freres, R. Marée, S. Wenric, K. Segers, J. Collignon, G. Jerusalem y V. Bours. "Genetic study of triple negative breast cancers". Annals of Oncology 26 (mayo de 2015): iii10. http://dx.doi.org/10.1093/annonc/mdv116.11.
Texto completoXu, Hong, Peter Eirew, Sarah C. Mullaly y Samuel Aparicio. "The Omics of Triple-Negative Breast Cancers". Clinical Chemistry 60, n.º 1 (1 de enero de 2014): 122–33. http://dx.doi.org/10.1373/clinchem.2013.207167.
Texto completoMalorni, L., P. B. Shetty, S. G. Hilsenbeck, M. F. Rimawi, R. M. Elledge, C. De Angelis, C. K. Osborne, S. De Placido y G. Arpino. "Triple-negative breast cancers: Biomarkers and outcomes." Journal of Clinical Oncology 28, n.º 15_suppl (20 de mayo de 2010): 10621. http://dx.doi.org/10.1200/jco.2010.28.15_suppl.10621.
Texto completoDžoić Dominković, Martina, Gordana Ivanac, Tomislav Kelava y Boris Brkljačić. "Elastographic features of triple negative breast cancers". European Radiology 26, n.º 4 (1 de agosto de 2015): 1090–97. http://dx.doi.org/10.1007/s00330-015-3925-7.
Texto completoBertucci, François, Pascal Finetti, Nathalie Cervera, Benjamin Esterni, Fabienne Hermitte, Patrice Viens y Daniel Birnbaum. "How basal are triple-negative breast cancers?" International Journal of Cancer 123, n.º 1 (2008): 236–40. http://dx.doi.org/10.1002/ijc.23518.
Texto completoSasaki, Yuka y Hitoshi Tsuda. "Clinicopathological characteristics of triple-negative breast cancers". Breast Cancer 16, n.º 4 (6 de agosto de 2009): 254–59. http://dx.doi.org/10.1007/s12282-009-0153-5.
Texto completoRegua, Angelina T., Dongqin Zhu, Daniel L. Doheny, Grace L. Wong, Sara G. Manore, Calvin J. Wagner, Austin Arrigo, Mariana Najjar y Hui-Wen Lo. "Abstract 1039: TrkA and JAK2-STAT3 pathway crosstalk promotes breast cancer stem cells in HER2-enriched and triple-negative breast cancers". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1039. http://dx.doi.org/10.1158/1538-7445.am2022-1039.
Texto completoGucalp, Ayca y Tiffany A. Traina. "Triple-Negative Breast Cancer: Adjuvant Therapeutic Options". Chemotherapy Research and Practice 2011 (21 de junio de 2011): 1–13. http://dx.doi.org/10.1155/2011/696208.
Texto completoBhatti, Abu Bakar Hafeez, Amina Iqbal Khan, Neelam Siddiqui, Nargis Muzaffar, Aamir Ali Syed, Mazhar Ali Shah y Arif Jamshed. "Outcomes of Triple-Negative Versus Non-Triple-Negative Breast Cancers Managed with Breast-Conserving Therapy". Asian Pacific Journal of Cancer Prevention 15, n.º 6 (30 de marzo de 2014): 2577–81. http://dx.doi.org/10.7314/apjcp.2014.15.6.2577.
Texto completoPareja, Fresia y Jorge S. Reis-Filho. "Triple-negative breast cancers — a panoply of cancer types". Nature Reviews Clinical Oncology 15, n.º 6 (19 de marzo de 2018): 347–48. http://dx.doi.org/10.1038/s41571-018-0001-7.
Texto completoNúñez Abad, Martín, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, María José Godes Sanz de Bremond, Clara García González, Susana Torres Martínez, José Ángel García-García, Vega Iranzo González-Cruz y Carlos Camps Herrero. "Update on systemic treatment in early triple negative breast cancer". Therapeutic Advances in Medical Oncology 13 (enero de 2021): 175883592098674. http://dx.doi.org/10.1177/1758835920986749.
Texto completoKim, Isaac, Katherine Sanchez, Heather L. McArthur y David Page. "Immunotherapy in Triple-Negative Breast Cancer: Present and Future". Current Breast Cancer Reports 11, n.º 4 (20 de noviembre de 2019): 259–71. http://dx.doi.org/10.1007/s12609-019-00345-z.
Texto completoKhandekar, Durga y Venkataswarup Tiriveedhi. "Role of BET Inhibitors in Triple Negative Breast Cancers". Cancers 12, n.º 4 (25 de marzo de 2020): 784. http://dx.doi.org/10.3390/cancers12040784.
Texto completoHu, Taobo, Yiqiang Liu, Jinbo Wu, Xuejiao Lina Hu, Guiyang Zhao, Baosheng Liang, Shu Wang y Mengping Long. "Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy". Journal of Clinical Medicine 11, n.º 6 (14 de marzo de 2022): 1607. http://dx.doi.org/10.3390/jcm11061607.
Texto completoManna, Subrata y Marina K. Holz. "Tamoxifen Action in ER-Negative Breast Cancer". Signal Transduction Insights 5 (enero de 2016): STI.S29901. http://dx.doi.org/10.4137/sti.s29901.
Texto completoAhmed, Muneer, A. Basit, R. Kirby, S. Narayanan y J. Adjogatse. "A comparison of triple negative versus triple positive breast cancers". European Journal of Surgical Oncology (EJSO) 37, n.º 11 (noviembre de 2011): 986. http://dx.doi.org/10.1016/j.ejso.2011.08.040.
Texto completoKeenan, Tanya E. y Sara M. Tolaney. "Role of Immunotherapy in Triple-Negative Breast Cancer". Journal of the National Comprehensive Cancer Network 18, n.º 4 (abril de 2020): 479–89. http://dx.doi.org/10.6004/jnccn.2020.7554.
Texto completoTryfonopoulos, Dimitrios, Georgios Oikonomopoulos, Stamatina Demiri, Lazaros Lekakis, Nikolaos Fragkiskos Pistamaltzian, George Koumakis, Chris G. Panopoulos et al. "Clinicopathologic characteristics of triple-negative breast cancer and relationship to basal markers." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e11519-e11519. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e11519.
Texto completo